Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMOX1: Intermittent vs Continuous Oxaliplatin in mCRC
NCT00006468Phase 3Unknown
- Sponsor
- GERCOR
- Start
- Jan 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in metastatic colorectal cancer (mCRC), sponsored by GERCOR. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00006468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006468.